Reach Us +44-1753390542
Olle Ringd | OMICS International
ISSN: 2161-0991

Journal of Transplantation Technologies & Research
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Olle Ringd

Division of Therapeutic Immunology and Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden


Prof. Ringdén is currently a distinguished professor at the Karolinska Institutet in Sweden. For over a decade, he worked as the director then the medical director at the Center for Allogeneic Stem Cell Transplantation at the Huddinge University Hospital in Stockholm.

After receiving his MD and PhD degrees from the Karolinska Institutet, Ringdén commenced his postdoctoral study at the Fred Hutchinson Cancer Research Center in Seattle, USA, in association with Nobel Laureate Donnal Thomas, where he was introduced to the fundamentals of transplantation biology. After his return to Karolinska, he established a stem cell research laboratory, where he, amongst other achievements, pioneered allogenic hematopoetic stem cell transplantation research in Sweden.

With the establishment of the Nordic Group for Blood and Marrow Transplantation (NMBT), Ringdén assumed a key role in research activities pertaining to proliferating and developing cytotoxic T lymphocytes (CTL) against viral and fungal infections, various (pre-) malignant lesions, and other clinically challenging targets.

Research Interest

Allogeneic Stem Cell Transplantation